BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7063753)

  • 21. Vasoactive intestinal peptide (VIP) as transmitter of inhibitory motor neurons of the gut: evidence from the use of selective VIP antagonists and VIP antiserum.
    Grider JR; Rivier JR
    J Pharmacol Exp Ther; 1990 May; 253(2):738-42. PubMed ID: 2110976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VIP and acetylcholine: neurotransmitters in esophageal circular smooth muscle.
    Behar J; Guenard V; Walsh JH; Biancani P
    Am J Physiol; 1989 Sep; 257(3 Pt 1):G380-5. PubMed ID: 2571301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of nitroxidergic nerve function by neurogenic acetylcholine in monkey cerebral arteries.
    Toda N; Ayajiki K; Okamura T
    J Physiol; 1997 Jan; 498 ( Pt 2)(Pt 2):453-61. PubMed ID: 9032692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neither vasoactive intestinal peptide (VIP) nor purine derivatives may mediate non-adrenergic tracheal inhibition.
    Karlsson JA; Persson CG
    Acta Physiol Scand; 1984 Dec; 122(4):589-98. PubMed ID: 6098141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-adrenergic inhibitory nerves and putative transmitters in the smooth muscle of cat trachea.
    Ito Y; Takeda K
    J Physiol; 1982 Sep; 330():497-511. PubMed ID: 7175755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasoactive intestinal peptide as a neural mediator of gastric relaxation.
    Grider JR; Cable MB; Said SI; Makhlouf GM
    Am J Physiol; 1985 Jan; 248(1 Pt 1):G73-8. PubMed ID: 3966563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vasoactive intestinal polypeptide as possible mediator of relaxation in the rat gastric fundus.
    De Beurme FA; Lefebvre RA
    J Pharm Pharmacol; 1988 Oct; 40(10):711-5. PubMed ID: 2907538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasoactive intestinal polypeptide (VIP) inhibits neurally evoked smooth muscle activity of rat uterine cervix in vitro.
    Stjernquist M; Owman C
    Regul Pept; 1984 Mar; 8(2):161-7. PubMed ID: 6328586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adrenergic and novel non-adrenergic neuronal mechanisms in the control of smooth muscle activity in the human oviduct.
    Lindblom B; Ljung B; Hamberger L
    Acta Physiol Scand; 1979 Jun; 106(2):215-20. PubMed ID: 228528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional role of vasoactive intestinal polypeptide in inhibitory motor innervation in the mouse internal anal sphincter.
    Keef KD; Saxton SN; McDowall RA; Kaminski RE; Duffy AM; Cobine CA
    J Physiol; 2013 Mar; 591(6):1489-506. PubMed ID: 23339175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for vasoactive intestinal peptide as a mediator of non-adrenergic non-cholinergic neurotransmission in the trachea.
    Venugopalan CS; Holmes EP; O'Malley NA
    J Auton Pharmacol; 1990 Oct; 10(5):297-304. PubMed ID: 1964680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasoactive intestinal polypeptide nerves in the human female genital tract.
    Alm P; Alumets J; Håkanson R; Helm G; Owman C; Sjöberg NO; Sundler F
    Am J Obstet Gynecol; 1980 Feb; 136(3):349-51. PubMed ID: 6101518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efffect of vasoactive intestinal polypeptide on gallbladder smooth muscle in vitro.
    Ryan JP; Ryave S
    Am J Physiol; 1978 Jan; 234(1):E44-6. PubMed ID: 623247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of cholinergic neural bronchoconstriction by endogenous nitric oxide and vasoactive intestinal peptide in human airways in vitro.
    Ward JK; Belvisi MG; Fox AJ; Miura M; Tadjkarimi S; Yacoub MH; Barnes PJ
    J Clin Invest; 1993 Aug; 92(2):736-42. PubMed ID: 8349813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of vasoactive intestinal polypeptide on the electrical activity of guinea-pig intestinal smooth muscle.
    Hills JM; Collis CS; Burnstock G
    Eur J Pharmacol; 1983 Apr; 88(4):371-6. PubMed ID: 6305677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effect of PACAP(6-38) on relaxations induced by PACAP, VIP and non-adrenergic, non-cholinergic nerve stimulation in the guinea-pig taenia caeci.
    Lénárd L; Lázár Z; Benkó R; Szigeti R; Báthori Z; Tóth GK; Penke B; Barthó L
    Naunyn Schmiedebergs Arch Pharmacol; 2000 May; 361(5):492-7. PubMed ID: 10832602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ATP and vasoactive intestinal polypeptide relaxant responses in hamster isolated proximal urethra.
    Pinna C; Puglisi L; Burnstock G
    Br J Pharmacol; 1998 Jul; 124(6):1069-74. PubMed ID: 9720775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of vasoactive intestinal polypeptide on the urinary bladder and taenia coli of the guinea pig.
    Johns A
    Can J Physiol Pharmacol; 1979 Jan; 57(1):106-8. PubMed ID: 427639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vagal control of nitric oxide and vasoactive intestinal polypeptide release in the regulation of gastric relaxation in rat.
    Takahashi T; Owyang C
    J Physiol; 1995 Apr; 484 ( Pt 2)(Pt 2):481-92. PubMed ID: 7602539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-amidated forms of VIP (glycine-extended VIP and VIP-free acid) have full bioactivity on smooth muscle.
    Fahrenkrug J; Ottesen B; Palle C
    Regul Pept; 1989 Dec; 26(3):235-9. PubMed ID: 2623188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.